Key points are not available for this paper at this time.
CAZ-AVI appears to be a promising drug for treatment of severe KPC-Kp infections, especially those involving bacteremia.
Building similarity graph...
Analyzing shared references across papers
Loading...
Mario Tumbarello
Ospedale Santa Maria alle Scotte
Enrico Maria Trecarichi
Ministero della Salute
Alberto Corona
Brescia University
Clinical Infectious Diseases
Sov. J. Nucl. Phys. (Engl. Transl.); (United States)
University of Milan
University of Bologna
Istituti di Ricovero e Cura a Carattere Scientifico
Building similarity graph...
Analyzing shared references across papers
Loading...
Tumbarello et al. (Wed,) studied this question.
synapsesocial.com/papers/6a0371250ef592079c2e6a35 — DOI: https://doi.org/10.1093/cid/ciy492
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: